108 EVALUATION OF A NOVEL BIOCERAMIC DRUG DELIVERY SYSTEM FOR TREATING HEPATOCELLULAR CARCINOMA (HCC) IN VIVO
β Scribed by J. Swet; K. Simo; H. Pacheco; D. Sindram; D. Iannitti; A. El-Ghannam; I. Mckillop
- Book ID
- 117380321
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 62 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The aim of this study was to estimate colon-specific drug delivery of a novel capsule (CS capsule). Theophylline was used as model drug and little was released from the CS capsules in the release medium mimicking physiological environment of stomach to small intestine. However, 66.7 +/- 8.8% theophy
## Abstract Multidrug resistant (MDR) cancer is difficult to treat. Chemicals that are effective MDR modulators have never exited clinical trials as FDA approved products due to side effects. It has been hypothesized that using a combination of chemotherapeutics with a mixture of MDR modulators (ea